Pediatric Metabolic and Bariatric Surgery and Antiobesity Medications: Weighing Efficacy, Risks, and Future Directions.
作者信息
Chinn Justine O, Woo Baidal Jennifer, Pratt Janey S A, Shepard W Elizabeth, Fell Gillian L
机构信息
Department of Surgery, Stanford University School of Medicine, Palo Alto, CA.
Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA.
出版信息
J Pediatr. 2025 Aug;283:114610. doi: 10.1016/j.jpeds.2025.114610. Epub 2025 Apr 17.
Abstract
摘要
相似文献
1
Pediatric Metabolic and Bariatric Surgery and Antiobesity Medications: Weighing Efficacy, Risks, and Future Directions.
J Pediatr. 2025 Aug;283:114610. doi: 10.1016/j.jpeds.2025.114610. Epub 2025 Apr 17.
2
EAES rapid guideline: systematic review, network meta-analysis, CINeMA and GRADE assessment, and European consensus on bariatric surgery-extension 2022.
Surg Endosc. 2022 Mar;36(3):1709-1725. doi: 10.1007/s00464-022-09008-0. Epub 2022 Jan 20.
3
Prepregnancy Roux-en-Y gastric bypass vs sleeve gastrectomy: a systematic review, pairwise, and network meta-analysis of obstetrical and neonatal outcomes.
Am J Obstet Gynecol MFM. 2023 Jun;5(6):100914. doi: 10.1016/j.ajogmf.2023.100914. Epub 2023 Mar 7.
4
Adverse event comparison between glucagon-like peptide-1 receptor agonists and other antiobesity medications following bariatric surgery.
Diabetes Obes Metab. 2024 Sep;26(9):3906-3913. doi: 10.1111/dom.15737. Epub 2024 Jun 27.
5
Comparative effectiveness of sleeve gastrectomy vs Roux-en-Y gastric bypass in patients giving birth after bariatric surgery: reinterventions and obstetric outcomes.
Surg Endosc. 2022 Sep;36(9):6954-6968. doi: 10.1007/s00464-022-09063-7. Epub 2022 Jan 31.
6
Comparative analysis of weight loss and resolution of comorbidities between laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass: A systematic review and meta-analysis based on 18 studies.
Int J Surg. 2020 Apr;76:101-110. doi: 10.1016/j.ijsu.2020.02.035. Epub 2020 Mar 6.
7
Roux-en-Y gastric bypass, adjustable gastric banding, or sleeve gastrectomy for severe obesity (By-Band-Sleeve): a multicentre, open label, three-group, randomised controlled trial.
Lancet Diabetes Endocrinol. 2025 May;13(5):410-426. doi: 10.1016/S2213-8587(25)00025-7. Epub 2025 Mar 31.
8
Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity: The SM-BOSS Randomized Clinical Trial.
JAMA. 2018 Jan 16;319(3):255-265. doi: 10.1001/jama.2017.20897.
9
Effect of laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy on fasting gastrointestinal and pancreatic peptide hormones: A prospective nonrandomized trial.
Surg Obes Relat Dis. 2018 Oct;14(10):1521-1529. doi: 10.1016/j.soard.2018.06.003. Epub 2018 Jun 14.
10
Association of Bariatric Surgery Using Laparoscopic Banding, Roux-en-Y Gastric Bypass, or Laparoscopic Sleeve Gastrectomy vs Usual Care Obesity Management With All-Cause Mortality.
JAMA. 2018 Jan 16;319(3):279-290. doi: 10.1001/jama.2017.20513.
本文引用的文献
1
Neoadjuvant Semaglutide, Bariatric Surgery Weight Loss, and Overall Outcomes.
JAMA Surg. 2025 May 1;160(5):594-596. doi: 10.1001/jamasurg.2025.0001.
2
Early Reinitiation of Obesity Pharmacotherapy Post Laparoscopic Sleeve Gastrectomy in Youth: A Retrospective Cohort Study.
Obes Surg. 2025 Feb;35(2):406-418. doi: 10.1007/s11695-024-07658-8. Epub 2025 Jan 11.
3
Integrating Genetic Insights, Technological Advancements, Screening, and Personalized Pharmacological Interventions in Childhood Obesity.
Adv Ther. 2025 Jan;42(1):72-93. doi: 10.1007/s12325-024-03057-8. Epub 2024 Nov 13.
4
Genetic Evidence for GLP-1 and GIP Receptors as Targets for Treatment and Prevention of MASLD/MASH.
Liver Int. 2025 Apr;45(4):e16150. doi: 10.1111/liv.16150. Epub 2024 Nov 2.
5
Ten-Year Outcomes after Bariatric Surgery in Adolescents.
N Engl J Med. 2024 Oct 31;391(17):1656-1658. doi: 10.1056/NEJMc2404054.
6
Metabolic Bariatric Surgery in the Era of GLP-1 Receptor Agonists for Obesity Management.
JAMA Netw Open. 2024 Oct 1;7(10):e2441380. doi: 10.1001/jamanetworkopen.2024.41380.
7
A cost comparison of GLP-1 receptor agonists and bariatric surgery: what is the break even point?
Surg Endosc. 2024 Nov;38(11):6560-6565. doi: 10.1007/s00464-024-11191-1. Epub 2024 Sep 16.
8
A pediatric primary care practice-based obesity intervention to support families: a cluster-randomized clinical trial.
Obesity (Silver Spring). 2024 Sep;32(9):1721-1733. doi: 10.1002/oby.24100. Epub 2024 Jul 30.
9
Comparative Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists in Children and Adolescents with Obesity or Overweight: A Systematic Review and Network Meta-Analysis.
Pharmaceuticals (Basel). 2024 Jun 24;17(7):828. doi: 10.3390/ph17070828.
10
Barriers to Care for Pediatric Patients with Obesity.
Life (Basel). 2024 Jul 17;14(7):884. doi: 10.3390/life14070884.
Zotero 插件